Shopping Cart
Remove All
Your shopping cart is currently empty
PDGFRα/β/VEGFR-2-IN-1 (6f) is a multi-targeted tyrosine kinase inhibitor that specifically targets PDGFRα, PDGFRβ, and VEGFR-2 kinases at nanomolar concentrations.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Backorder | Backorder | |
| 50 mg | Inquiry | Backorder | Backorder |
| Description | PDGFRα/β/VEGFR-2-IN-1 (6f) is a multi-targeted tyrosine kinase inhibitor that specifically targets PDGFRα, PDGFRβ, and VEGFR-2 kinases at nanomolar concentrations. |
| In vitro | PDGFRα/β/VEGFR-2-IN-1 (6f) is an effective compound against pancreatic ductal adenocarcinoma cell lines MDA-PATC53 and PL45, while exhibiting a good safety profile in normal prostate epithelial cells (RWPE-1). It disrupts the G2/M cell cycle transition by upregulating p21 and reducing the mRNA levels of CDK1 and cyclin B1. |
| Formula | C23H16BrClN2O3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.